Attempt to validate breakpoint MIC values estimated from pharmacokinetic data obtained during oxolinic acid therapy of winter ulcer disease in Atlantic salmon (Salmo salar)
- 1 September 2004
- journal article
- Published by Elsevier in Aquaculture
- Vol. 238 (1-4) , 51-66
- https://doi.org/10.1016/j.aquaculture.2004.04.027
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Dosage regime experiments with oxolinic acid and flumequine in Atlantic salmon (Salmo salar L) held in seawaterAquaculture, 2002
- Development of draft protocols of standard reference methods for antimicrobial agent susceptibility testing of bacteria associated with fish diseasesAquaculture, 2001
- Quality measures of antimicrobial drug useInternational Journal of Antimicrobial Agents, 2000
- Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisationInternational Journal of Antimicrobial Agents, 2000
- Characterization of Vibrio viscosus and Vibrio wodanis isolated at different geographical locations: a proposal for reclassification of Vibrio viscosus as Moritella viscosa comb. nov.International Journal of Systematic and Evolutionary Microbiology, 2000
- Aquaculture antibacterials are antagonized by seawater cationsJournal of Fish Diseases, 1995
- High-performance liquid chromatographic analysis of oxytetracycline in chinook salmon following administration of medicated feedJournal of Chromatography A, 1991
- Bioavailability of oxolinic acid in Atlantic salmon (Salmo salar L. ) from medicated feedAquaculture, 1991
- Absorption, distribution and elimination of oxolinic acid in Atlantic salmon (Salmo salar L.) after various routes of administrationAquaculture, 1991
- Comparative pharmacokinetics and bioavailability of oxolinic acid and oxytetracycline in rainbow trout (Oncorhynchus mykiss)Xenobiotica, 1991